The CF33, Vaxinia and Oncarlytics Deal, page-325

Hi Tsack @Tsack and TBull @Taureanbull and Choi @fattchoi

Thank you for your comments ... they add to the IMU discussion in an informed and very useful way.
Perhaps I should also thank Mason (although on my ignore list) for sparking the above replies. He is
a capable poster on his own threads, but is often found to be very 'selective' when throwing 'data' around
on thread where he doesn't hold. I always find that attitude interesting, but that's probably should be another
post at another time.

Tsack: Its great to see a post from someone who has worked in Big Pharma. The examples you have offered
are both enlightening for our IMU crowd, and thought provoking. So many things can impact on the success of
any product, hence we see differing outcomes in your examples.

You are certainly 'on the money' when you say ... The truth is that for a drug to be successful, it needs many
things in order to be a commercial success.
I disagree to a point, when you say ... Safety and efficacy are just one thing. But the marketing is where the
magic happens.

I would suggest you need SAFETY, EFFICACY, AFFORDABILITY and MARKETING (and probably more).

TBull: You are very much 'on the money', in my opinion when saying ... IMU are bring a whole new field of
therapy into play. It’s also cheap and efficient to deliver, as opposed to so many very effective and promising
cellular therapies.

And also when 'filling' the trial ... recruitment for Vaccinia has been quick and easy. They have trial volunteers
lined up around the block. That tells us , this product will sell itself if the trial results are good.
Very few if any side affects is enough to sell the product! ... At this stage it’s looking like a ‘cure’ as opposed
to a small life extension. Absolutely cannot argue - it does look more like a cure, than short term relief.

Choi: And then you 'round out' the argument nicely with ... as long as Vaccinia is at least as safe and effective
than any drug out there for any treatment, low cost will have government backings and they will sell for IMU.
Any other countries that do not have such luxury of a government funded treatment ... low cost will win out again.

Perhaps you guys should work as a team. It is, after all, the great team at IMU, that could finally deliver the
knock out blow to cancer. I certainly hope so anyway.

It's so often the case that a 'down-ramper', who is busy 'trolling' another company, actually inspires the
total opposite. It makes me laugh. Love it.